UROLIFT IPN929207Recalls & reported problems
Teleflex Incorporated · UroLift UL2 ATC Implant Cartridge · Class 2 · Implant
All models of UROLIFT (13)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 4
- Deaths reported
- 0
- Injuries reported
- 2
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 4 adverse event reports that list this exact device (DI 10814932020459), received between Dec 5, 2024 and Sep 9, 2026 — classified as 2 injuries, 2 malfunctions.
The most frequently reported specific device problem is “Firing Problem” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem2
- Firing Problem1
- Material Rupture1
Patient problems
- Hematuria2
- Urinary Retention2
- No Clinical Signs, Symptoms or Conditions1
- Skin Inflammation/ Irritation1
Recent adverse event reports
The 4 most recent of 4 reports, in the reporter's own words as published by the FDA.
MalfunctionSep 9, 2026Firing Problem
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 50690138 ↗MalfunctionNov 19, 2025Material Rupture; Material Rupture
IT WAS REPORTED " NOTICED THROUGHOUT THE PROCEDURE CARTRIDGES WERE SLIGHTLY MORE DIFFICULT TO INSERT BUT STILL SEEMED TO BE LOCKING IN PROPERLY. BEFORE PLACING THE 6TH IMPLANT, THE DELIVERY SYSTEM NEEDED TO BE RESET. IT SEEMED LIKE THE TRIGGER HADN'T BEEN FULLY RETRACTED AFTER LAST IMPLANT DELIVERY. PHYSICIAN SUCCESSFULLY INSERTED ATC CARTRIDGE INTO DELIVERY SYSTEM AND ATTEMPTED PLACEMENT ON PATIENTS LEFT PROXIMAL SLIGHTLY ANTERIOR TO FIRST PROXIMAL IMPLANT. AFTER RETRACTING NEEDLE/3RD PULL THE KEYHOLE SHOWED METAL THAT LOOKED LIKE THE NEEDLE, NOT A CT OR UE. SUCCESSFULLY REMOVED DELIVERY SYSTEM BUT THE TIP OF DELIVERY SYSTEM SHOWED THE NEEDLE WAS BROKEN IN HALF. WE USED VO TO LOOK INSIDE PATIENT AND SAW NEEDLE TIP FLOATING AT THE BASE OF THE BLADDER. PHYSICIAN USED A GRASPER TO REMOVE TIP OF NEEDLE THROUGH RIGID CYSTO SHEATH. PATIENT HAD SOME IRRITATION TO THE BLADDER WALL FROM NEEDLE WHICH RESULTED IN PLACEMENT OF A CATHETER. PATIENT HAD CATHETER REMOVED NEXT DAY AND DOES NOT REPORT ANY ADDITIONAL CONCERNS".
Patient problems: Skin Inflammation/ Irritation
MAUDE report 23594425 ↗InjuryDec 5, 2024Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
ON (B)(6) 2024, NEOTRACT HAS BEEN MADE AWARE BY A [PHYSICIAN] THAT ¿TWO PATIENTS WHO UNDERWENT THE PROSTATIC URETHRAL LIFT (PUL) PROCEDURE ON (B)(6) 2024, REQUIRED READMISSION TO THE HOSPITAL DUE TO HEMATURIA AND CLOT RETENTION. ACCORDING TO [PHYSICIAN], ONE PATIENT REQUIRED A RETURN TO THE OPERATING ROOM FOR CLOT EVACUATION. [PHYSICIAN] NOTED THAT BLEEDING EVENTS OF THIS NATURE ARE NOT UNCOMMON FOLLOWING BENIGN PROSTATIC HYPERPLASIA (BPH) PROCEDURES.¿ ON (B)(6) 2024, A LABEL PHOTO OF THE DEVICE WAS PROVIDED. ADDITIONAL INFORMATION RECEIVED ON NOVEMBER 12, 2024, INDICATED THAT FOUR HOURS AFTER UNDERGOING THE UROLIFT PROCEDURE, THE PATIENT EXPERIENCED HEMATURIA AND CLOT RETENTION. THE PATIENT WAS ALREADY ADMITTED TO THE HOSPITAL AT THE TIME AND UNDERWENT SURGICAL INTERVENTION TO REMOVE THE CLOTS. THE PATIENT¿S CONDITION WAS REPORTED TO BE FINE FOLLOWING THE PROCEDURE. THE FACILITY ADDRESS, DEVICE LOT NUMBER, AND PHYSICIAN CONTACT INFORMATION WERE ALSO PROVIDED.
Patient problems: Hematuria; Urinary Retention
MAUDE report 20850557 ↗InjuryDec 5, 2024Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
ON (B)(6) 2024, NEOTRACT HAS BEEN MADE AWARE BY A [PHYSICIAN] THAT ¿TWO PATIENTS WHO UNDERWENT THE PROSTATIC URETHRAL LIFT (PUL) PROCEDURE ON OCTOBER 31, 2024, REQUIRED READMISSION TO THE HOSPITAL DUE TO HEMATURIA AND CLOT RETENTION. ACCORDING TO [PHYSICIAN], ONE PATIENT REQUIRED A RETURN TO THE OPERATING ROOM FOR CLOT EVACUATION. [PHYSICIAN] NOTED THAT BLEEDING EVENTS OF THIS NATURE ARE NOT UNCOMMON FOLLOWING BENIGN PROSTATIC HYPERPLASIA (BPH) PROCEDURES.¿ ON (B)(6) 2024, A LABEL PHOTO OF THE DEVICE WAS PROVIDED. ADDITIONAL INFORMATION RECEIVED ON NOVEMBER 12, 2024, INDICATED THAT ONE OF THE PATIENTS EXPERIENCED HEMATURIA AND CLOT RETENTION IN THE EVENING FOLLOWING THE UROLIFT PROCEDURE. THE PATIENT HAD ALREADY BEEN ADMITTED TO THE HOSPITAL AT THAT TIME AND UNDERWENT CLOT EVACUATION SURGERY. POST-SURGERY, THE PATIENT WAS REPORTED TO BE FINE. THE FACILITY ADDRESS, DEVICE LOT NUMBER, AND PHYSICIAN CONTACT INFORMATION WERE ALSO PROVIDED.
Patient problems: Hematuria; Urinary Retention
MAUDE report 20850547 ↗
Other Implantable transprostatic tissue retractor system devices
- UroLift UL400-4Neotract, Inc. · Implantable Transprostatic Tissue Retractor System1 recall9 deaths144 reports
- UroLift UL400-4Neotract, Inc. · Implantable Transprostatic Tissue Retractor System1 recall3 reports
- UROLIFT IPN924184Teleflex Incorporated · Implantable transprostatic tissue retractor system1 death32 reports
- UROLIFT IPN918876Teleflex Incorporated · Implantable transprostatic tissue retractor system18 reports
- UROLIFT IPN923352Teleflex Incorporated · Implantable transprostatic tissue retractor system15 reports
- UROLIFT IPN055826Teleflex Incorporated · Implantable transprostatic tissue retractor system15 reports
- UROLIFT IPN056134Teleflex Incorporated · Implantable transprostatic tissue retractor system1 death10 reports
- UROLIFT IPN056885Teleflex Incorporated · Implantable transprostatic tissue retractor system10 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page